Velcade and thrombocytopenia Patient Reports February 11, 2012

Velcade Side Effects Report #5599223-8
Velcade side effect was reported by a Physician from UNITED STATES on Jan 08, 2008. Male patient, 68 years of age, weighting 198.2 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac disorder, megakaryocytes decreased, multi-organ failure, no therapeutic response, pulmonary haemorrhage, thrombocytopenia. Velcade dosage: 2.17 MG,. Patient was hospitalized. Patient died on 11/23/2007.

Velcade Side Effects Report #4882552-0
Velcade side effect was reported by a Physician from UNITED STATES on Dec 29, 2005. Female patient, 54 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, infection , mouth ulceration, pyrexia, rash , syncope, thrombocytopenia, vasculitis . Velcade dosage: unknown. During the same period patient was treated with BACTRIM, ZOMETA. Patient recovered.

Velcade Side Effects Report #5029012-4
Velcade side effect was reported by a Physician from FRANCE on June 06, 2006. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: pulmonary haemorrhage, thrombocytopenia. Velcade dosage: 2.76MG, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DOXIL, CYCLOPHOSPHAMIDE, METHOTREXATE, CORTAN, BLEOMYCIN. Patient died on 06/03/2006.

Velcade Side Effects Report #5034472-9
Velcade side effect was reported by a Physician from FRANCE on June 09, 2006. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, febrile neutropenia, pulmonary haemorrhage, thrombocytopenia. Velcade dosage: 2.76 MG INTRAVENOUS. During the same period patient was treated with DOXYL, CYCLOPHOSPHAMIDE, METHOTREXATE, CORTAN, BLEOMYCIN. Patient was hospitalized. Patient died on 06/03/2006.


Velcade Side Effects Report #5042533-3
Velcade side effect was reported by a Physician from FRANCE on June 16, 2006. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain upper, condition aggravated, cough, febrile neutropenia, histiocytosis haematophagic, lymphoma , pulmonary haemorrhage, thrombocytopenia. Velcade dosage: 2.76 MG, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DOXIL, CYCLOPHOSPHAMIDE, METHOTREXATE, CORTAN, BLEOMYCIN. Patient was hospitalized. Patient died on 06/03/2006.

Velcade Side Effects Report #5468239-4
Velcade side effect was reported by a Physician from FRANCE on Sept 12, 2007. Female patient, 56 years of age, weighting 103.6 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, dysphagia, hiatus hernia, oesophagitis ulcerative, oral candidiasis, thrombocytopenia. Velcade dosage: 2.40 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN, METHOTREXATE, MESNA, GRANOCYTE, VALACYCLOVIR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5746193-5
Velcade side effect was reported by a Physician from FRANCE on May 06, 2008. Female patient, 56 years of age, weighting 103.6 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: aphthous stomatitis, febrile bone marrow aplasia, feeding disorder, odynophagia, oesophageal candidiasis, oral candidiasis, thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN SULPHATE, METHOTREXATE, PREDNISONE, GRANOCYTE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5424476-6
Velcade side effect was reported by a Physician from FRANCE on Aug 13, 2007. Female patient, 54 years of age, weighting 97.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, dysphagia, febrile neutropenia, oesophagitis, thrombocytopenia. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN, GRANOCYTE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5744894-6
Velcade side effect was reported by a Physician from FRANCE on May 06, 2008. Female patient, 54 years of age, weighting 97.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, asthenia, febrile neutropenia, mucosal inflammation, oesophagitis, thrombocytopenia. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with ADRIBLASTINE, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN SULPHATE, GRANOCYTE. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #4998489-2
Velcade side effect was reported by a Physician from FRANCE on Apr 25, 2006. Female patient, 54 years of age, weighting 97.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, febrile bone marrow aplasia, oesophagitis, thrombocytopenia. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5013908-3
Velcade side effect was reported by a Physician from FRANCE on May 17, 2006. Female patient, 54 years of age, weighting 97.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aplasia, diarrhoea, febrile neutropenia, mucosal inflammation, oesophagitis, thrombocytopenia. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with ADRIABLASTINE, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN, GRANOCYTE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5013974-5
Velcade side effect was reported by a Physician from UNITED STATES on May 16, 2006. Male patient, 50 years of age, weighting 198.0 lb, was diagnosed with prostate cancer  and was treated with Velcade. After drug was administered, patient experienced the following side effects: flatulence, ileus, infusion related reaction, pneumonia aspiration, small intestinal obstruction, thrombocytopenia. Velcade dosage: 1.6 MG/M2, IV BOULUS. During the same period patient was treated with PRILOSEC. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5270415-0
Velcade side effect was reported by a Physician from GERMANY on Mar 09, 2007. Female patient, 77 years of age, weighting 134.5 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with ZOFRAN. Patient recovered.

Velcade Side Effects Report #5281239-2
Velcade side effect was reported by a Physician from GERMANY on Mar 14, 2007. Female patient, 77 years of age, weighting 134.5 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with ZOFRAN. Patient recovered.


Velcade Side Effects Report #5270421-6
Velcade side effect was reported by a Physician from GERMANY on Mar 09, 2007. Male patient, 65 years of age, weighting 178.6 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ZOFRAN. Patient recovered.

Velcade Side Effects Report #5283168-7
Velcade side effect was reported by a Physician from GERMANY on Mar 14, 2007. Male patient, 65 years of age, weighting 178.6 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ZOFRAN. Patient recovered.

Velcade Side Effects Report #5958358-8
Velcade side effect was reported by a Health Professional from UNITED STATES on Nov 04, 2008. Male patient, 79 years of age, weighting 155.2 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , chronic obstructive pulmonary disease, fall , hypotension, pneumonia , pulmonary embolism , sepsis , thrombocytopenia, urinary tract infection . Velcade dosage: 2 MG/M2, INTRAVENOUS. During the same period patient was treated with ALIMTA, ESCITALOPRAM, POTASSIUM, MIDODRINE HYDROCHLORIDE, ACETAMINOPHEN AND OXYCODONE, SPIRIVA, VITAMINS, ASPIRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5087189-9
Velcade side effect was reported by a Physician from PHILIPPINES on Aug 10, 2006. Male patient, 88 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: herpes zoster, thrombocytopenia. Velcade dosage: unknown. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5354877-6
Velcade side effect was reported by a Physician from UNITED STATES on May 31, 2007. Male patient, 71 years of age, weighting 183.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , blood creatinine increased, cellulitis , febrile neutropenia, groin abscess, groin pain, thrombocytopenia. Velcade dosage: 1.50 MG/M2, INTRAVENOUS. During the same period patient was treated with TYLENOL, CARVEDILOL, VICODIN, COLACE, DOXAZOSIN, ESOMEPRAZOLE, NITROGLYCERIN, HYDROXIDE. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5104151-8
Velcade side effect was reported by a Physician from FRANCE on Aug 29, 2006. Female patient, 53 years of age, weighting 132.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: thrombocytopenia, vaginal haemorrhage. Velcade dosage: 2.40 MG, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5117921-7
Velcade side effect was reported by a Physician from FRANCE on Sept 11, 2006. Female patient, 53 years of age, weighting 132.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: thrombocytopenia, uterine polyp, vaginal haemorrhage. Velcade dosage: unknown. During the same period patient was treated with ARACYTINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5348257-7
Velcade side effect was reported by a Physician from FRANCE on May 22, 2007. Female patient was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, haemorrhage, haemorrhoidal haemorrhage, mouth haemorrhage, petechiae, thrombocytopenia. Velcade dosage: 2.28 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5466071-9
Velcade side effect was reported by a Physician from FRANCE on Aug 29, 2007. Female patient was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemorrhoidal haemorrhage, petechiae, thrombocytopenia. Velcade dosage: 2.28 MG,. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6067854-7
Velcade side effect was reported by a Physician from UNITED STATES on Jan 21, 2009. Male patient, 85 years of age, weighting 196.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atelectasis, barrett's oesophagus, blood creatinine increased, body temperature increased, dehydration, dyspnoea, pleural effusion, thrombocytopenia. Velcade dosage: 2.5 MG/M2, INTRAVENOUS. During the same period patient was treated with ALKERAN, PREDNISONE. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #4629287-7
Velcade side effect was reported by a Health Professional from on Mar 24, 2005. Female patient, 85 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, dysuria, faecaloma, international normalised ratio increased, thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, FUROSEMIDE, SPIRONOLACTONE, DIGOXIN, ATENOLOL, COUMADIN, LEVOTHROID, SURFAK. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5268353-2
Velcade side effect was reported by a Consumer or non-health professional from PORTUGAL on Mar 02, 2007. Male patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haematoma, thrombocytopenia. Velcade dosage: unknown. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5569873-3
Velcade side effect was reported by a Physician from UNITED STATES on Dec 06, 2007. Female patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacteraemia, malignant neoplasm progression, multiple myeloma , neutropenia, sepsis , thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with REVLIMID. Patient died on 06/26/2007.

Velcade Side Effects Report #5753981-8
Velcade side effect was reported by a Pharmacist from FRANCE on May 13, 2008. Male patient, 81 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, gait disturbance, insomnia, muscle atrophy, nausea , sensory loss, thrombocytopenia, weight decreased. Velcade dosage: unknown. During the same period patient was treated with FENTANYL, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4786124-8
Velcade side effect was reported by a Physician from FRANCE on Sept 14, 2005. Male patient, 81 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bradyphrenia, confusional state, gait disturbance, hyponatraemia, thrombocytopenia, urinary incontinence . Velcade dosage: 2.00 MG, 2/WEEK, INTRAVENOUS; 1.00 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE PHOSPHATE. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #4617005-8
Velcade side effect was reported by a Health Professional from on Dec 14, 2004. Male patient, 80 years of age, weighting 173.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , contusion, rectal haemorrhage, thrombocytopenia. Velcade dosage: 2.30 MG, IV BOLUS. Patient recovered.

Velcade Side Effects Report #5049202-4
Velcade side effect was reported by a Health Professional from UNITED STATES on Feb 25, 2006. Male patient, 80 years of age, weighting 163.1 lb, was diagnosed with multiple myeloma , prophylaxis and was treated with Velcade. After drug was administered, patient experienced the following side effects: small intestinal obstruction, thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with COMPAZINE, MECLIZINE, FERROUS SULPHATE, DILTIAZEM, HYDROCORTISONE, LEVOTHYROXINE, NITROGLYCERIN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4616555-8
Velcade side effect was reported by a Physician from on Jan 31, 2005. Female patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, injection site discolouration, muscle spasms, rash erythematous, thrombocytopenia, urticaria. Velcade dosage: 2.50 MG, IV BOLUS; 2.00 MG, IV BOLUS; 2.50 MG, IV BOLUS; 2.00 MG. Patient recovered.

Velcade Side Effects Report #5316527-4
Velcade side effect was reported by a Physician from AUSTRALIA on Apr 18, 2007. Female patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, disease progression, hyperviscosity syndrome, thrombocytopenia. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ROMIDEPSIN. Patient died on 04/17/2007.

Velcade Side Effects Report #5122645-6
Velcade side effect was reported by a Consumer or non-health professional from SPAIN on Sept 22, 2006. Male patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, constipation , dry eye, face oedema, haematuria, herpes zoster, thrombocytopenia, vision blurred. Velcade dosage: 1.30 MG/M2. Patient recovered.


Velcade Side Effects Report #5509025-6
Velcade side effect was reported by a Physician from AUSTRALIA on Oct 24, 2007. Female patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: amyloidosis, cerebral haemorrhage, disease progression, febrile infection, hyperviscosity syndrome, infusion site infection, thrombocytopenia. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ROMIDEPSIN. Patient was hospitalized. Patient died on 04/17/2007.

Velcade Side Effects Report #4788886-2
Velcade side effect was reported by a Physician from FRANCE on Sept 20, 2005. Female patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: dermatitis bullous, pruritus, rash maculo-papular, thrombocytopenia. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with CORTANCYL, ZOMETA. Patient recovered.

Velcade Side Effects Report #4801316-7
Velcade side effect was reported by a Physician from FRANCE on Sept 27, 2005. Female patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: dermatitis bullous, pruritus, rash maculo-papular, thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with CORTANCYL, ZOMETA. Patient recovered.

Velcade Side Effects Report #4807905-8
Velcade side effect was reported by a Physician from FRANCE on Oct 06, 2005. Female patient, 78 years of age, weighting 198.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aphthous stomatitis, dermatitis bullous, pruritus, rash maculo-papular, thrombocytopenia, toxic skin eruption. Velcade dosage: unknown. During the same period patient was treated with CORTANCYL, ZOMETA, ANTIHYPERTENSIVES. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5216781-3
Velcade side effect was reported by a Physician from PORTUGAL on Jan 10, 2007. Female patient, 77 years of age, weighting 140.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemorrhage, nervous system disorder, thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with OMEPRAZOLE, DILTIAZEM, ERYTHROPOIETIN. Patient was hospitalized. Patient died on 10/24/2006.


Velcade Side Effects Report #5161081-3
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Nov 08, 2006. Female patient, 76 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, duodenal ulcer haemorrhage, haematocrit decreased, haemoglobin decreased, thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, ASTRIX, ACECLOFENAC, OXYCONTIN, LASIX, DIMENHYDRINATE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4680988-4
Velcade side effect was reported by a Health Professional from on May 17, 2005. Male patient, 76 years of age, weighting 208.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood pressure decreased, dizziness , haematocrit decreased, haematotoxicity, haemoglobin decreased, thrombocytopenia. Velcade dosage: 2.80 MG. During the same period patient was treated with LEKOVIT CA, FOLIC ACID, COLACE, SENNA, VALTREX, OXYCODONE, PAXIL. Patient recovered.

Velcade Side Effects Report #4709485-4
Velcade side effect was reported by a Health Professional from UNITED STATES on June 17, 2005. Male patient, 76 years of age, weighting 208.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood pressure decreased, condition aggravated, dizziness , haematotoxicity, heart rate increased, thrombocytopenia. Velcade dosage: 2.80 MG, INTRAVENOUS. During the same period patient was treated with LEKOVIT CA, FOLIC ACID, COLACE, SENNA, VALTREX, OXYCODONE, PAXIL. Patient recovered.

Velcade Side Effects Report #4752988-7
Velcade side effect was reported by a Health Professional from UNITED STATES on Aug 08, 2005. Female patient, 76 years of age, weighting 125.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: angina pectoris, angina unstable, anti-platelet antibody positive, bone pain, chest pain , decreased appetite, thrombocytopenia, weight decreased. Velcade dosage: unknown. During the same period patient was treated with LOPRESSOR, ACIPHEX, ALEVE, VITAMINS, ZOMETA, ARANESP, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4989206-0
Velcade side effect was reported by a Physician from UNITED STATES on Feb 10, 2006. Male patient, 76 years of age, weighting 194.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , apathy, asthenia, depressed level of consciousness, headache , hyponatraemia, nausea , thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with ZOFRAN, ZOMETA, ARANESP, COREG, CYMBALTA, NEXIUM, COMPAZINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5368127-8
Velcade side effect was reported by a Physician from GREECE on June 12, 2007. Male patient, 75 years of age, weighting 194.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abasia, dysstasia, fatigue, thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5376666-9
Velcade side effect was reported by a Physician from GREECE on June 17, 2007. Male patient, 75 years of age, weighting 194.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease, fatigue, ileus paralytic, megacolon, respiratory tract infection, sepsis , thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with METHYLPREDNISOLONE, ITRACONAZOLE, CEFTRIAXONE, MOXIFLOXACIN, METRONIDAZOLE, FLUCONAZOLE, VORICONAZOLE, ERYTHROMYCIN. Patient was hospitalized. Patient died on 06/16/2007.

Velcade Side Effects Report #5397318-5
Velcade side effect was reported by a Physician from GREECE on July 10, 2007. Male patient, 75 years of age, weighting 194.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease, fatigue, ileus paralytic, megacolon, respiratory tract infection, sepsis , thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with METHYLPREDNISOLONE, ITRACONAZOLE, CEFTRIAXONE, MOXIFLOXACIN, METRONIDAZOLE, FLUCONAZOLE, VORICONAZOLE, ERYTHROMYCIN. Patient was hospitalized. Patient died on 06/16/2007.

Velcade Side Effects Report #5483860-5
Velcade side effect was reported by a Physician from GREECE on Sept 27, 2007. Male patient, 75 years of age, weighting 194.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abasia, dysstasia, fatigue, ileus paralytic, megacolon, respiratory tract infection, sepsis , thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with METHYLPREDNISOLONE, ITRACONAZOLE, CEFTRIAXONE, MOXIFLOXACIN, METRONIDAZOLE, FLUCONAZOLE, VORICONAZOLE, ERYTHROMYCIN. Patient was hospitalized. Patient died on 06/16/2007.

Velcade Side Effects Report #5551276-9
Velcade side effect was reported by a Health Professional from ISRAEL on Nov 29, 2007. Female patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: fluid retention, hyponatraemia, thrombocytopenia. Velcade dosage: unknown. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #6010616-7
Velcade side effect was reported by a Physician from FRANCE on Dec 03, 2008. Male patient, 75 years of age, weighting 196.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , diarrhoea, diverticulum intestinal, helicobacter infection, subileus, thrombocytopenia, weight decreased. Velcade dosage: 1.3 MG/M2, 1 MG. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6084282-9
Velcade side effect was reported by a Physician from GREECE on Feb 03, 2009. Male patient, 75 years of age, weighting 194.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abasia, fatigue, ileus paralytic, megacolon, respiratory tract infection, sepsis , thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, METHYLPREDNISOLONE, ITRACONAZOLE, CEFTRIAXONE, MOXIFLOXACIN, METRONIDAZOLE, FLUCONAZOLE, VORICONAZOLE. Patient was hospitalized. Patient died on 06/16/2007.

Velcade Side Effects Report #4815360-7
Velcade side effect was reported by a Pharmacist from UNITED STATES on Oct 13, 2005. Female patient, 75 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, international normalised ratio increased, thrombocytopenia. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with ATENOLOL, VEXOL, TIMOPTIC, ALPHAGAN, OLMESARTAN MEDOXOMIL, COUMADIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4827759-3
Velcade side effect was reported by a Pharmacist from UNITED STATES on Oct 26, 2005. Female patient, 75 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, international normalised ratio increased, prothrombin time prolonged, thrombocytopenia, treatment noncompliance. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with WARFARIN, ATENOLOL, TIMOPTIC, ALPHAGAN, OLMESARTAN MEDOXOMIL, COUMADIN, TYLENOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4830543-8
Velcade side effect was reported by a Pharmacist from UNITED STATES on Oct 26, 2005. Female patient, 75 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, disease progression, international normalised ratio increased, prothrombin time prolonged, thrombocytopenia. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with COUMADIN, ATENOLOL, VEXOL, TIMOPTIC, ALPHAGAN, OLMESARTAN MEDOXOMIL, TYLENOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4879651-6
Velcade side effect was reported by a Physician from RUSSIAN FEDERATION on Dec 28, 2005. Female patient, 75 years of age, weighting 145.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: angina pectoris, pneumonia , respiratory failure, thrombocytopenia. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with ARIFON, AREDIA. Patient was hospitalized. Patient died on 12/21/2005.

Velcade Side Effects Report #5642145-4
Velcade side effect was reported by a Physician from JAPAN on Feb 13, 2008. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , disease progression, hypoaesthesia, nausea , pneumonia aspiration, pyrexia, thrombocytopenia. Velcade dosage: 1.80 MG, INTRAVENOUS; 1.40 MG, INTRAVENOUS. During the same period patient was treated with HYDROCORTISONE SUCCINATE, NIFEDIPINE, PROTECADIN, ALLOPURINOL, BICARBONATE, SOLITA T, PRIMPERAN. Patient died on 10/23/2007.

Velcade Side Effects Report #5679486-0
Velcade side effect was reported by a Physician from JAPAN on Mar 12, 2008. Male patient, 74 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: decreased appetite, diarrhoea, disease progression, hyperuricaemia, neuropathy peripheral, pyrexia, thrombocytopenia, tumour lysis syndrome. Velcade dosage: 2.00 MG,INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, AMLODIPINE BESYLATE, URALYT, DIFLUCAN, VALSARTAN, BAKTAR, LAFUTIDINE, FOSAMAX. Patient died on 10/13/2007.

Velcade Side Effects Report #5951645-9
Velcade side effect was reported by a Physician from FRANCE on Oct 29, 2008. Female patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemorrhage, thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #5274570-8
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Mar 13, 2007. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute myocardial infarction, thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with GATIFLOXACIN, PAMIDRONATE DISODIJM, MEFENAMIC ACID. Patient died on 01/29/2007.


Velcade Side Effects Report #5292555-2
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Mar 23, 2007. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute myocardial infarction, condition aggravated, hypertension, multiple myeloma , thrombocytopenia. Velcade dosage: 1.30 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with GATIFLOXACIN, PAMIDRONATE DI, MEFENAMIC ACID. Patient died on 01/29/2007.

Velcade Side Effects Report #5376668-2
Velcade side effect was reported by a Physician from SWITZERLAND on June 18, 2007. Male patient, 73 years of age, weighting 185.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: lymphoma , malignant neoplasm progression, thrombocytopenia. Velcade dosage: 2.60 MG, INTRAVENOUS. Patient died on 02/10/2007.

Velcade Side Effects Report #5811426-3
Velcade side effect was reported by a Physician from HUNGARY on July 07, 2008. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, disease progression, multiple myeloma , pneumonia , sepsis , thrombocytopenia. Velcade dosage: 2.3 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE. Patient was hospitalized. Patient died.

Velcade Side Effects Report #6023756-3
Velcade side effect was reported by a Physician from JAPAN on Dec 12, 2008. Female patient, 73 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, c-reactive protein increased, capillary leak syndrome, constipation , hyperphosphatasaemia, pyrexia, thrombocytopenia, tumour lysis syndrome. Velcade dosage: 1.8 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LAXOBERON, SENNOSIDE A, SORBITOL, LECICARBON, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4769124-3
Velcade side effect was reported by a Health Professional from UNITED STATES on Aug 03, 2005. Male patient, 73 years of age, weighting 155.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, renal failure acute, thrombocytopenia. Velcade dosage: 1.80 MG, SINGLE, INTRAVENOUS. During the same period patient was treated with ARANESP. Patient was hospitalized. Patient died on 05/18/2005.

Velcade Side Effects Report #4924595-4
Velcade side effect was reported by a Health Professional from CANADA on Feb 06, 2006. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, haemorrhage, thrombocytopenia. Velcade dosage: 2.50 MG. During the same period patient was treated with NORVASC. Patient died on 02/04/2006.

Velcade Side Effects Report #5284477-8
Velcade side effect was reported by a Physician from AUSTRALIA on Mar 16, 2007. Male patient, 72 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypercalcaemia, paraproteinaemia, thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with ROMIDEPSIN, DEXAMETHASONE, THALIDOMIDE, ACCUPRIL, MAGNESIUM ASPARTATE, NORVASC, ZOMETA, SEPTRINTE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5379570-5
Velcade side effect was reported by a Physician from AUSTRALIA on June 19, 2007. Male patient, 72 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypercalcaemia, paraproteinaemia, plasmapheresis, thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with ROMIDEPSIN, DEXAMETHASONE, THALIDOMIDE, ACCUPRIL, MAGNESIUM ASPARTATE, NORVASC, ZOMETA, SEPTRINTE. Patient was hospitalized. Patient died on 05/10/2007.

Velcade Side Effects Report #5907654-9
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Sept 17, 2008. Male patient, 72 years of age, weighting 145.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, disease progression, dyspnoea, multiple myeloma , myocardial infarction, neuropathy peripheral, pleural effusion, thrombocytopenia. Velcade dosage: 2.2 MG; 1.6 MG. Patient died on 07/25/2008.

Velcade Side Effects Report #6028291-4
Velcade side effect was reported by a Physician from GERMANY on Dec 22, 2008. Female patient, 72 years of age, weighting 145.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aplasia, bone marrow failure, escherichia sepsis, thrombocytopenia. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE. Patient was hospitalized. Patient died on 11/08/2008.


Velcade Side Effects Report #4707639-4
Velcade side effect was reported by a Physician from SWITZERLAND on June 17, 2005. Female patient, 72 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, cardiac failure, disease progression, renal failure, thrombocytopenia. Velcade dosage: 1.80 MG 2/WEEK INTRAVENOUS. During the same period patient was treated with FOSAMAX. Patient died on 04/28/2005.

Velcade Side Effects Report #5301270-8
Velcade side effect was reported by a Physician from BRAZIL on Mar 30, 2007. Female patient, 71 years of age, weighting 156.5 lb, was diagnosed with multiple myeloma , bone pain and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, condition aggravated, neuropathy, spinal cord compression, thrombocytopenia, weight decreased. Velcade dosage: 1.30 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with TYLEX, CODEINE SUL, ACETAMINOPHEN, TRAMADOL. Patient recovered.

Velcade Side Effects Report #5574021-X
Velcade side effect was reported by a Health Professional from FRANCE on Dec 10, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, axonal neuropathy, dehydration, thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5601977-9
Velcade side effect was reported by a Physician from UNITED STATES on Jan 10, 2008. Male patient, 71 years of age, weighting 140.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cachexia, deep vein thrombosis , pain , pleural effusion, pneumonia , pulmonary embolism , thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXIL, THALIDOMIDE, ACYCLOVIR, LOMOTIL, ENULOSE, FENTANYL, MEGACE, OXYCODONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5074645-2
Velcade side effect was reported by a Physician from UNITED STATES on July 19, 2006. Female patient, 70 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, haemorrhage, loss of consciousness, lung infiltration, pleural effusion, sepsis , thrombocytopenia, urinary incontinence , vomiting. Velcade dosage: unknown. Patient was hospitalized. Patient died on 04/30/2006.

Velcade Side Effects Report #5123327-7
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Sept 26, 2006. Female patient, 70 years of age, weighting 93.48 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: loss of consciousness, neutropenia, pneumonia , respiratory failure, sepsis , thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with AIRTAL, TRIAZOLAM, CALCIUM CARBONATE, GANATON, METOCLOPRAMIDE, CYTOTEC, MEGACE, DIGOXIN. Patient was hospitalized. Patient died on 09/21/2006.

Velcade Side Effects Report #5162120-6
Velcade side effect was reported by a Physician from PORTUGAL on Nov 09, 2006. Female patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: thrombocytopenia. Velcade dosage: 1.30 MG/M2, UNK, INTRAVENOUS. Patient was hospitalized. Patient died on 10/01/2006.

Velcade Side Effects Report #5384252-X
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2006. Female patient, 70 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemorrhage, thrombocytopenia. Velcade dosage: 0.70 MG/M2, INTRAVENOUS, 300.00 MG/M2, INTRAVENOUS. During the same period patient was treated with ZOFRAN, ATIVAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5384332-9
Velcade side effect was reported by a Physician from UNITED STATES on Aug 10, 2006. Male patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: thrombocytopenia, transaminases increased. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #5455043-6
Velcade side effect was reported by a Physician from FRANCE on Sept 03, 2007. Female patient, 70 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, polyneuropathy, thrombocytopenia. Velcade dosage: 2.25 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LYRICA. Patient died on 02/05/2007.


Velcade Side Effects Report #5460701-3
Velcade side effect was reported by a Physician from RUSSIAN FEDERATION on Sept 10, 2007. Female patient, 70 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: agranulocytosis, anaemia, thrombocytopenia. Velcade dosage: 1.70 MG, INTRAVENOUS. During the same period patient was treated with ETAMSILATE, RECORMON. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5493476-2
Velcade side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Oct 08, 2007. Male patient, 70 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: catheter related infection, decreased appetite, infusion related reaction, malaise, nausea , thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS, 1.00 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5589467-3
Velcade side effect was reported by a Physician from JAPAN on Dec 28, 2007. Female patient, 70 years of age, weighting 94.80 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: agranulocytosis, thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5677807-6
Velcade side effect was reported by a Physician from JAPAN on Mar 06, 2008. Female patient, 70 years of age, weighting 94.80 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: agranulocytosis, thrombocytopenia. Velcade dosage: 1.60 MG, INTRAVENOUS; 1.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #5698788-5
Velcade side effect was reported by a Physician from JAPAN on Mar 26, 2008. Female patient, 70 years of age, weighting 94.80 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: agranulocytosis, disease progression, neuropathy peripheral, thrombocytopenia, white blood cell count decreased. Velcade dosage: 1.60 MG, INTRAVENOUS, 1.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died on 02/17/2008.

Velcade Side Effects Report #5911847-4
Velcade side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Sept 19, 2008. Male patient, 70 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: decreased appetite, malaise, nausea , thrombocytopenia. Velcade dosage: 1.3 MG/M2, INTRAVENOUS; 1 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4616800-9
Velcade side effect was reported by a Consumer or non-health professional from on Feb 02, 2005. Female patient, 70 years of age, weighting 159.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, epistaxis, hyperviscosity syndrome, mental status changes, thrombocytopenia. Velcade dosage: 1.00 MG, 2/WEEK. During the same period patient was treated with ALLOPURINOL, ZOMETA, LASIX, POTASSIUM CHLORIDE, MS CONTIN, PAXIL, SENNA. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4692445-X
Velcade side effect was reported by a Consumer or non-health professional from on Apr 29, 2005. Female patient, 70 years of age, weighting 159.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, epistaxis, hyperviscosity syndrome, mental status changes, thrombocytopenia. Velcade dosage: 1.00 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, ZOMETA, LASIX, POTASSIUM CHLORIDE, MS CONTIN, PAXIL, SENNA. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5024005-5
Velcade side effect was reported by a Physician from UNITED STATES on May 24, 2006. Female patient, 70 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemorrhage, loss of consciousness, sepsis , thrombocytopenia. Velcade dosage: 1.00 MG, INTRAVENOUS. Patient was hospitalized. Patient died on 04/30/2006.

Velcade Side Effects Report #5049528-4
Velcade side effect was reported by a Physician from UNITED STATES on Apr 27, 2006. Female patient, 70 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemorrhage, thrombocytopenia. Velcade dosage: 300.00 MG/M2, IV BOLUS. During the same period patient was treated with ZOFRAN, ATIVAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5049538-7
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 21, 2006. Female patient, 70 years of age, weighting 159.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, epistaxis, hyperviscosity syndrome, mental status changes, thrombocytopenia. Velcade dosage: 1.00 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, ZOMETA, LASIX, POTASSIUM CHLORIDE, MS CONTIN, PAXIL, SENNA. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5049555-7
Velcade side effect was reported by a Physician from UNITED STATES on Apr 27, 2006. Female patient, 70 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemorrhage, thrombocytopenia. Velcade dosage: 1.00 MG, IV BOLUS. During the same period patient was treated with ZOFRAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5298336-8
Velcade side effect was reported by a Physician from JAPAN on Apr 03, 2007. Female patient, 69 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, leukopenia, pyrexia, thrombocytopenia. Velcade dosage: 1.70 MG. During the same period patient was treated with PIPERACILLIN, FAMOTIDINE, MAGNESIUM OXIDE, ADALAT, ISOSORBIDE MONONITRATE, SIMVASTATIN, MOBIC, BAKTAR. Patient recovered.

Velcade Side Effects Report #5367277-X
Velcade side effect was reported by a Physician from JAPAN on June 07, 2007. Female patient, 69 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, leukopenia, pyrexia, thrombocytopenia. Velcade dosage: 1.70 MG. During the same period patient was treated with PIPERACILLIN, FAMOTIDINE, MAGNESIUM OXIDE, ADALAT, ISOSORBIDE MONONITRATE, SIMVASTATIN, MOBIC, SULFAMETHOXAZOLE. Patient recovered.

Velcade Side Effects Report #5054024-4
Velcade side effect was reported by a Physician from GERMANY on July 03, 2006. Male patient, 69 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, pneumonia , pyrexia, thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LEVOFLOXACIN, PANTOZOL, ENOXAPARIN, VORICONAZOLE. Patient died on 02/13/2006.

Velcade Side Effects Report #5074767-6
Velcade side effect was reported by a Physician from GERMANY on July 28, 2006. Male patient, 69 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, disease progression, pneumonia , pyrexia, thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LEVOFLOXACIN, PANTOZOL, ENOXAPARIN, VORICONAZOLE. Patient died on 02/13/2006.

Velcade Side Effects Report #5084876-3
Velcade side effect was reported by a Physician from GERMANY on Aug 03, 2006. Male patient, 69 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, malignant neoplasm progression, plasmacytoma, pneumonia , pyrexia, stem cell transplant, thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with BENDAMUSTINE, MELPHALAN, DEXAMETHASONE, LEVOFLOXACIN, PANTOZOL, ENOXAPARIN, VORICONAZOLE. Patient died on 02/13/2006.

Velcade Side Effects Report #5162805-1
Velcade side effect was reported by a Physician from UNITED STATES on Nov 13, 2006. Male patient, 69 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, capillary leak syndrome, cardiac failure, disease progression, fluid overload, pulmonary oedema, thrombocytopenia. Velcade dosage: unknown. Patient was hospitalized. Patient died on 01/01/2003.

Velcade Side Effects Report #5165720-2
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Nov 16, 2006. Male patient, 69 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, infection , malignant neoplasm progression, multiple myeloma , thrombocytopenia. Velcade dosage: unknown. Patient was hospitalized. Patient died on 09/14/2006.

Velcade Side Effects Report #5387598-4
Velcade side effect was reported by a Physician from JAPAN on June 29, 2007. Female patient, 69 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, leukopenia, pyrexia, thrombocytopenia. Velcade dosage: 1.70 MG. During the same period patient was treated with PIPERACILLIN, FAMOTIDINE, MAGNESIUM OXIDE, ADALAT, ISOSORBIDE MONONITRATE, SIMVASTATIN, MOBIC, SULFAMETHOXAZOLE. Patient recovered.

Velcade Side Effects Report #5954886-X
Velcade side effect was reported by a Physician from SPAIN on Nov 05, 2008. Female patient, 69 years of age, weighting 156.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , subdural haemorrhage, thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient died on 10/01/2008.

Velcade Side Effects Report #5959610-2
Velcade side effect was reported by a Physician from SPAIN on Nov 07, 2008. Female patient, 69 years of age, weighting 156.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, head injury, multiple myeloma , subdural haemorrhage, thrombocytopenia. Velcade dosage: 2.2 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient died on 10/01/2008.

Velcade Side Effects Report #4892167-6
Velcade side effect was reported by a Physician from UNITED STATES on Jan 09, 2006. Male patient, 69 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, capillary leak syndrome, cardiac disorder, cardiac failure, fluid overload, pulmonary oedema, thrombocytopenia. Velcade dosage: unknown. Patient was hospitalized. Patient died.